StockData

Goldenwell Biotech, Inc. (GWLL) stock

GWLLOTCFood and Kindred ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.65+0.05 (+8.33%)

Close on Oct 19, 2026Market cap $64.35MP/E –Yield –

Goldenwell Biotech total assets

Total assets on the balance sheet at the end of each period.

Goldenwell Biotech's total assets was $28.98K at Jun 30, 2026. For fiscal 2025 it was $36.12K, down 83.9% from the year before. The highest annual figure on record is $460.98K in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$36.12K-83.9%
FY2024Dec 31, 2024$224.19K-1.7%
FY2023Dec 31, 2023$228.09K-8.2%
FY2022Dec 31, 2022$248.40K-46.1%
FY2021Dec 31, 2021$460.98K+85.5%
FY2020Dec 31, 2020$248.57K+0.8%
FY2019Dec 31, 2019$246.59K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$28.98K-89.2%
Q1 FY2026Mar 31, 2026$18.75K-90.2%
Q4 FY2025Dec 31, 2025$36.12K-83.9%
Q3 FY2025Sep 30, 2025$233.76K+30.3%
Q2 FY2025Jun 30, 2025$267.32K+33.4%
Q1 FY2025Mar 31, 2025$191.92K-3.5%
Q4 FY2024Dec 31, 2024$224.19K-1.7%
Q3 FY2024Sep 30, 2024$179.43K-4.0%
Q2 FY2024Jun 30, 2024$200.40K+4.2%
Q1 FY2024Mar 31, 2024$198.97K-9.3%
Q4 FY2023Dec 31, 2023$228.09K-8.2%
Q3 FY2023Sep 30, 2023$186.93K-29.7%
Q2 FY2023Jun 30, 2023$192.34K-29.9%
Q1 FY2023Mar 31, 2023$219.42K-28.9%
Q4 FY2022Dec 31, 2022$248.40K-46.1%
Q3 FY2022Sep 30, 2022$266.08K-45.2%
Q2 FY2022Jun 30, 2022$274.40K-46.1%
Q1 FY2022Mar 31, 2022$308.69K-29.1%
Q4 FY2021Dec 31, 2021$460.98K+85.5%
Q3 FY2021Sep 30, 2021$485.85K+93.9%
Q2 FY2021Jun 30, 2021$509.18K+106.5%
Q1 FY2021Mar 31, 2021$435.18K–
Q4 FY2020Dec 31, 2020$248.57K–
Q3 FY2020Sep 30, 2020$250.54K–
Q4 FY2019Dec 31, 2019$246.59K–

More Goldenwell Biotech figures

See a number that looks wrong?